Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.28M | -6.03M | 391.00K | -5.43M | -6.23M |
| Total Depreciation and Amortization | 386.00K | 471.00K | 626.00K | 880.00K | 1.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.66M | 3.41M | -3.59M | -2.21M | -1.75M |
| Change in Net Operating Assets | 2.76M | 1.90M | 583.00K | 2.34M | 1.70M |
| Cash from Operations | -472.00K | -251.00K | -1.99M | -4.43M | -5.23M |
| Capital Expenditure | -5.00K | -7.00K | -5.00K | -2.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 57.00K | 57.00K | 57.00K | 509.00K | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.00K | -57.00K | -114.00K | -612.00K | -612.00K |
| Cash from Investing | -5.00K | -7.00K | -62.00K | -105.00K | -614.00K |
| Total Debt Issued | 1.07M | 2.81M | 2.81M | 2.81M | 2.81M |
| Total Debt Repaid | -1.04M | -1.27M | -905.00K | -894.00K | -912.00K |
| Issuance of Common Stock | -- | -- | -- | 5.00M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 1.26M |
| Repurchase of Preferred Stock | -- | -- | -- | -1.26M | -1.26M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.00K | -12.00K | -12.00K | -1.00M | -1.00M |
| Cash from Financing | 14.00K | 1.53M | 1.89M | 4.65M | 5.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -463.00K | 1.27M | -163.00K | 118.00K | 56.00K |